C. Frank Bennett, SVP, Antisense Research at IONIS PHARMACEUTICALS INC (IONS), sold 12,500 shares at $45.00 ($563K) on 2018-08-08, disclosed to the SEC on 2018-08-09.
Open-market sale of $562k IONS by SVP, Antisense Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 13 | $585 | 0.1% |
| 2 | $45.00 | 12,487 | $562K | 99.9% |
| Total | $45.00 avg | 12,500 | $563K | 100% |
| Filing → |
| IONS | SELL | 2026-02-04 | $14.1M | — | Filing → |
| IONS | SELL | 2026-02-02 | $976K | — | Filing → |
| IONS | SELL | 2026-01-20 | $675K | — | Filing → |